P. Nofi Michael's most recent trade in SpringWorks Therapeutics Inc was a trade of 78,300 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on July 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| SpringWorks Therapeutics Inc | Nofi Michael P. | Chief Accounting Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 78,300 | 0 | - | - | Stock Option (Right to Buy) | |
| SpringWorks Therapeutics Inc | P. Nofi Michael | Chief Accounting Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 65,000 | 0 | - | - | Stock Option (Right to Buy) | |
| SpringWorks Therapeutics Inc | P. Michael Nofi | Chief Accounting Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 40,000 | 0 | - | - | Stock Option (Right to Buy) | |
| SpringWorks Therapeutics Inc | Nofi Michael P. | Chief Accounting Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 30,623 | 0 (0%) | 0% | - | Common Stock | |
| SpringWorks Therapeutics Inc | Michael Nofi P. | Chief Accounting Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 20,246 | 0 | - | - | Stock Option (Right to Buy) | |
| SpringWorks Therapeutics Inc | Nofi Michael P. | Chief Accounting Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 8,661 | 0 | - | - | Performance Share Units | |
| SpringWorks Therapeutics Inc | Michael Nofi P. | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 20,246 | 20,246 | - | - | Stock Option (Right to Buy) | |
| SpringWorks Therapeutics Inc | Michael Nofi P. | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 6,929 | 30,623 (0%) | 0% | 0 | Common Stock | |
| SpringWorks Therapeutics Inc | Michael Nofi P. | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.19 per share. | 04 Jan 2025 | 2,388 | 26,339 (0%) | 0% | 38.2 | 91,198 | Common Stock |
| SpringWorks Therapeutics Inc | Michael Nofi P. | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.19 per share. | 04 Jan 2025 | 1,636 | 24,703 (0%) | 0% | 38.2 | 62,479 | Common Stock |
| SpringWorks Therapeutics Inc | Michael Nofi P. | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.86 per share. | 04 Jan 2025 | 1,009 | 23,694 (0%) | 0% | 38.9 | 39,210 | Common Stock |